Scienture Holdings, Inc. SEC filings SCNX
Scienture Holdings, Inc. has 507 filings in SEC EDGAR's recent list, going back to Jun 15, 2007. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Sep 18, 2026 | Sep 18, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 8, 2026 | Sep 8, 2026 |
| DEF 14A | Proxy statement | Oct 24, 2025 | Oct 23, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 7, 2025 | Oct 6, 2025 |
| DEFA14A | Additional proxy material | Feb 18, 2025 | — |
| DEF 14A | Proxy statement | Jan 27, 2025 | Jan 27, 2025 |
| DEF 14C | Information statement | Dec 30, 2024 | Dec 30, 2024 |
| PRE 14C | Filing | Dec 20, 2024 | Dec 20, 2024 |
| DEF 14C | Information statement | Aug 28, 2024 | Aug 28, 2024 |
| PRE 14C | Filing | Aug 16, 2024 | Aug 15, 2024 |
| PRE 14A | Preliminary proxy statement | May 17, 2024 | May 17, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 14, 2023 | Aug 14, 2023 |
| DEF 14A | Proxy statement | May 25, 2023 | May 25, 2023 |
| PRE 14A | Preliminary proxy statement | May 9, 2023 | May 8, 2023 |
| DEFA14A | Additional proxy material | Nov 9, 2022 | — |
| DEF 14A | Proxy statement | Nov 9, 2022 | Nov 9, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 24, 2022 | Oct 24, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 21, 2022 | Apr 21, 2022 |
| DEFA14A | Additional proxy material | Apr 16, 2021 | — |
| DEF 14A | Proxy statement | Apr 16, 2021 | Apr 16, 2021 |
| DEFA14A | Additional proxy material | Apr 16, 2020 | — |
| DEF 14A | Proxy statement | Apr 16, 2020 | Apr 16, 2020 |
| DEF 14C | Information statement | Oct 23, 2019 | Oct 22, 2019 |
| PRE 14C | Filing | Sep 27, 2019 | Sep 27, 2019 |
| DEF 14C | Information statement | Oct 9, 2018 | Oct 9, 2018 |
| PRE 14C | Preliminary 14c information statement | Sep 27, 2018 | Sep 27, 2018 |
| DEF 14C | Information statement | Oct 26, 2017 | Oct 26, 2017 |
| PRE 14C | Preliminary 14c information statement | Oct 16, 2017 | Oct 16, 2017 |
| DEF 14C | Information statement | Aug 3, 2016 | Aug 3, 2016 |
| PRE 14C | Schedule 14c preliminary information statement | Jul 19, 2016 | Jul 18, 2016 |
| DEF 14C | Information statement | May 18, 2015 | May 18, 2015 |
| PRE 14C | Preliminary 14c information statement | May 4, 2015 | Apr 28, 2015 |
| DEF 14C | Information statement | Nov 12, 2008 | Nov 12, 2008 |
| PRE 14C | Bluebird exploration pre 14c 103008 | Oct 30, 2008 | Oct 30, 2008 |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SCNX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Commack, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1382574
- Former names
- TRxADE HEALTH, INC (until Aug 28, 2024); TRXADE GROUP, INC. (until May 28, 2021); XCELLINK INTERNATIONAL INC. (until Jan 31, 2014); Bluebird Exploration Co. (until Dec 10, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.